1,542
Participants
Start Date
August 2, 2022
Primary Completion Date
August 5, 2024
Study Completion Date
May 27, 2025
Drospirenone
LPRI-CF113 consists of 24 active white tablets containing drospirenone (DRSP) 4 mg followed by 4 active pink tablets containing DRSP 2.8 mg, taken orally once daily for 28 consecutive days, in consecutive cycles for 12 months (13 medication cycles) without a break in daily tablet intake.
Clinical Research of Philadelphia, Philadelphia
Virginia Women's Health Associates, Reston
Eastern Virginia Medical School (EVMS), Norfolk
Unified Women's Clinical Research - Winston-Salem, Winston-Salem
Unified Women's Clinical Research - Raleigh, Raleigh
Eastern Carolina Women's Center, New Bern
Coastal Carolina Research Center, North Charleston
The Research Center of the Upstate, Greenville
Fellows Research Alliance, Savannah
Cornerstone Research Institute - Longwood, Altamonte Springs
Direct Helpers Research Center, Hialeah
Inpatient Research Clinic, LLC, Hialeah
Vital Pharma Research, Inc., Hialeah
Encore Medical Research, LLC, Hollywood
American Research Centers of Florida, Pembroke Pines
Global Research Associates, Homestead
Florida International Medical Research, Miami
Segal Institute for Clinical Research, North Miami
New Age Medical Research Corporation, Miami
SJ Research Institute, Miami
Encore Medical Research of Weston LLC, Weston
Comprehensive Clinical Trials, West Palm Beach
Encore Medical Research of Boynton Beach LLC., Boynton Beach
Altus Research, Lake Worth
Women's Medical Research Group, Clearwater
Alabama Clinical Therapeutics, LLC, Alabaster
Alabama Clinical Therapeutics, LLC, Birmingham
Chattanooga Medical Research, Chattanooga
Clinohio Research Services, Columbus
AC Clinical Research, Tiffin
Southern Clinical Research Associates, Metairie
Praetorian Pharmaceutical Research, Marrero
Eastern Clinical Research Associates, New Orleans
Discovery Clinical Trials, Dallas
FMC Science, Lampasas
TMC Life Research, Houston
Mt. Olympus Medical Research- Sugar Land Texas, Sugar Land
Maximos OB/GYN, League City
Clinical Trials of Texas, LLC, San Antonio
Austin Regional Clinic ARC Clinical Research at Kelly Lan, Pflugerville
Central Texas Clinical Research, Austin
Clinical Research Prime, Idaho Falls
Leavitt Clinical Research, Idaho Falls
Rosemark WomenCare Specialists, Idaho Falls
Del Sol Research Management, Tucson
Eclipse Clinical Research, Tucson
Clinique RS, Québec
Lead Sponsor
Collaborators (1)
Chemo Research
INDUSTRY
Insud Pharma
INDUSTRY